Associations between baseline level and clinical, anthropometric and behavioral changes in adults and the elderly diagnosed with hypertension and/or diabetes: a prospective cohort study Authors: Emily de Souza Ferreira, Vanessa de Souza Amaral, Lara Camargo de Oliveira, Michele Duarte Pereira, Tabata Isabely Souza Neves, Tiago Ricardo Moreira, Glauce Dias da Costa, Rosângela Minardi Mitre Cotta Published: 2026 ABSTRACT AbstractBackgroundMultimorbidity is defined as the presence of two or more multifactorial diseases or conditions. In this context, the focus of this study is on arterial hypertension (AH) and diabetes, two chronic diseases with high global prevalence and incidence, whose clinical, physical, and behavioral factors must be critically analyzed over the long term, particularly within the primary care setting, where interventions are most effective and impactful. The objective of the study was to prospectively assess baseline levels of clinical, physical, and behavioral parameters and their changes over three years in adults and older adults with AH and/or diabetes receiving primary care.MethodsA three-year prospective cohort study involving 357 individuals previously diagnosed with AH and/or diabetes. These individuals received an intervention based on general guidance regarding health care, healthy choices, and positive behavioral changes. This intervention took place at the beginning of the study (T0 – baseline) and at the end of the study (T1 – follow-up), and the patients were divided as follows: Group 1 (diabetes diagnosis only); Group 2 (AH only); and Group 3 (diabetes and AH). Changes in physical, clinical, anthropometric, and behavioral parameters among the groups were statistically analyzed between T0 and T1 using the Kruskal–Wallis H test and the chi-square test. Additionally, post hoc multiple comparisons were performed using Tukey’s test and Dunn’s test with Bonferroni adjustment. Effect sizes were estimated using Cohen’s d with corresponding 95% confidence intervals.ResultsWithin-group comparisons revealed a significant reduction in physical activity levels in Group 2, while Group 3 showed improvements in HbA1c (d = − 0.40; p = 0.034), SBP (p = 0.025), DBP (p = 0.003), and BMI (p = 0.003). Between-group comparisons at T1 indicated moderate to large differences in triglycerides (d = 0.53; p = 0.009), which increased over the follow-up period and a significant difference in light physical activity (d = 0.35; p = 0.043).ConclusionsThe results indicate that lifestyle improvements in patients diagnosed with hypertension and/or diabetes are associated with improvements in cardiometabolic indicators. Although group interventions are important, individualized approaches tend to promote better adherence and self-care, demonstrating that chronic disease management strategies in primary care can help reduce the burden on health care services.Trial registrationBrazilian Registry of Clinical Trials (ReBEC), ID: RBR-45hqzmf.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12889-026-27701-w.Keywords: Health promotion, Health management, Primary care, Diabetes, Hypertension, Aging Introduction The Arterial Hypertension (AH) represents a major global challenge for public health, due to its increasing incidence and prevalence and its associated diseases, with emphasis on cardiovascular diseases, mortality from all causes and hypertensive heart disease [1–4]. The hypertensive heart disease manifests as a consequence of prolonged high blood pressure and is also an underlying mechanism for the incidence and mortality from cardiovascular diseases [3]. In this same scenario, there is Diabetes, which, together with AH, can affect the same individual, as they share similar physiological mechanisms, including cardiovascular disease and obesity [1]. This context configures multimorbidity, which is defined as the presence of two or more diseases or conditions [5, 6]. In this case, we highlight the two chronic non-communicable diseases mentioned above: Diabetes and AH. Added to this equation is the ageing population, which contributes to the emergence of these and other diseases and/or conditions, resulting in an increase in multimorbidity [5, 6]. In addition, these diseases are multifactorial, and many of these factors are behavioral and modifiable (smoking, sedentary lifestyle and poor diet) [7–9]. For this reason, some innovative and sustainable approaches are being employed, all of them in line with the Sustainable Development Goals of the World Health Organization, which advocates that primary care should be placed at the center of improving the quality of life and well-being of the population [10]. It is common to note that primary and secondary health care services generally focus on a single disease, and this is also the focus of many epidemiological studies [6]. Therefore, studies that analyze multicausality and especially its consequences in primary care need to be further explored, since it is at this level of health care that risk factors are addressed, monitored and can prevent a negative outcome of chronic diseases, as is the case in this study. In addition to the focus on a single disease, another gap commonly faced in primary care is the type of community or individual intervention carried out for people who have one or more chronic diseases. Recently, remote monitoring and other strategies related to telehealth have gained more attention and are being used in health services, however, there is still a restriction on resources for this purpose, as well as other important issues related to user acceptance and protection of patient data [11]. Most clinical guidelines, as well as training and healthcare delivery, remain focused on isolated diseases, leading to sometimes inadequate and potentially harmful care for individuals with multimorbidity (reference). Furthermore, the behavioral factors associated with multimorbidity are poorly understood from a longitudinal perspective, highlighting the need for a better understanding of multimorbidity clusters and their trajectories over time in different population characteristics. Some cohort studies carried out so far have only analyzed the association between the baseline level of glycated hemoglobin (HbA1c) and incident Diabetes, and the same goes for AH, disregarding the impact of the dynamic changes that occur in these levels over the course of the patient’s follow-up. This study, objective was to prospectively evaluate the baseline levels of clinical, physical, and behavioral parameters and their changes over three years in adults and elderly individuals with hypertension and/or diabetes followed in primary health care. Methods Study design This is an ongoing prospective cohort using research data from the Telehealth Center of the Federal University of Viçosa (NUTELES-UFV), registered with the National Institute of Industrial Property in 2024, under Process No. BR512024004537-6. NUTELES-UFV is part of a large longitudinal intervention study based on Telemonitoring and Teleeducation based on two main study groups: the control group and the intervention group [12]. In this wide-ranging research project at NUTELES-UFV, we are working on one main intervention, which is the use of digital health in its two axes for monitoring and following up people diagnosed with AH and/or Diabetes, and the traditional intervention, which is face-to-face clinical consultations at health units and general guidance regarding health care, healthy choices, and positive behavioral changes. For the purposes of this study, we will work with the control group that received the second type of intervention at the initial moment of the study (T0 - baseline) and at the final moment (T1 - follow-up). At the T0, patients were informed that the next part of the research would be the repetition of the measurements and interview and that this would occur in a few months. Sample size calculation For the sample calculation, the formula for quantitative variables in unpaired samples was used [13]. The standard deviation value for the reference parameter was 0.62 for the traditional intervention group [14]. A 95% confidence level, 84% power, and a 0.2 margin of error were considered. Based on this, a sample size of 313 individuals was determined. The sample was distributed proportionally, based on the number of people with AH and diabetes, among the nine municipalities where the study was conducted, and 20% was added to account for potential follow-up losses, totaling approximately 375 participants. The sampling process for individuals diagnosed with AH and/or diabetes was conducted in two stages. First, the sample size was calculated by municipality within the Viçosa health micro-region, Minas Gerais, Brazil. The second stage involved calculating the proportion of people with the aforementioned conditions that each municipality represented relative to the total calculated sample size. Study participants This study focused on adult and elderly individuals from nine municipalities in the health microregion of Viçosa, Minas Gerais, Brazil, which is part of the Zona da Mata of the state of Minas Gerais, Brazil. In total, participants were recruited from 19 primary health care units in the microregion. Among the 375 participants in the traditional intervention group, 18 were excluded due to lack of complete data, because they didn’t meet the inclusion criteria and/or because they didn’t agree to participate in the research. Thus, there are a total of 357 individuals diagnosed with AH and/or Diabetes who met the inclusion criteria and provided written informed consent to participate in the research (Fig. 1). Study participant flow chart The following inclusion criteria were considered: age over 18 years; being followed up in primary health care units and with a confirmed diagnosis of AH and/or Diabetes. Were excluded from the study patients with serious clinical conditions requiring specialized care, pregnant women and individuals with a history of alcohol and/or drug abuse, bedridden or wheelchair patients. All individuals provided informed consent prior to enrollment. This sample of 375 participants came from the NUTELES/UFV longitudinal intervention study, in which individuals with a prior diagnosis of AH and/or diabetes were allocated to intervention and control groups through randomization with a computer-generated random sequence. However, in the present study, there was no additional randomization, since the analysis was restricted to participants in the control group, who were allocated to three groups according to the clinical diagnosis established in the initial assessment: (1) diabetes only, (2) AH only, and (3) concomitant presence of both conditions. The blinding procedures (patients, healthcare professionals, and data analyst) were defined in the NUTELES/UFV longitudinal study. In the present study, no additional blinding strategies were applied. Ethics approval and consent to participate All procedures in this study were approved by the Human Research Ethics Committee of the Federal University of Viçosa, under opinion no. 4.475.901 and registered, prior to recruitment, by the Brazilian Registry of Clinical Trials (ReBEC), ID: RBR-45hqzmf (Last approval date: 11/30/2022, available in: https://ensaiosclinicos.gov.br/rg/RBR-45hqzmf) in accordance with Resolution no. 466/2012 of the National Health Council, which regulates research involving human beings. As part of the informed consent process, people received clear information about the objectives of the study, their rights as research subjects, and the benefits and possible risks involved. The privacy and confidentiality of the data collected from the participants were ensured by the use of codes to identify the questionnaires and specimens completed by the participants. Data collection All team members were properly trained and qualified to conduct the interview using a questionnaire previously created and tested through an extensive literature review and consultation with experts in the field [12]. This questionnaire has 70 questions subdivided into 12 classes. For the present study, data related to (1) sociodemographic characteristics (age, sex, race, education level, location of the house and marital status), (2) health status (information on existing comorbidities), (3) adverse events (whether the patient was affected by the SARS-CoV1 virus), (4) clinical evaluation (measurement of diastolic blood pressure - DBP and systolic blood pressure - SBP), (5) physical examination (anthropometric measurements such as body mass index and waist circumference), (6) assessment of risk factors (smoking and alcoholism), (7) level of physical activity (information on the practice of light and moderate physical activity and its frequency) and (8) laboratory tests (information on fasting blood glucose, HbA1c, creatinine, total cholesterol, triglycerides and high-density lipoprotein - HDL) were used. The level of education of individuals was categorized into three groups (no education, primary to elementary school, and elementary to higher education), while marital status was classified into four groups: single, married, separated, and widowed. Smokers were considered those who smoked at least one cigarette per day, while alcohol consumption was considered for users who consumed any alcoholic beverage more than once a week. Data on physical activity were collected based on the validated questionnaire by Matsudo [15]. We classified the level of physical activity between light and moderate considering the time of each activity multiplied by the days in the week in which they were performed. We considered light physical activity to be those individuals who practice exercises that require little physical effort, causing a small increase in breathing and heart rate. Moderate physical activity, on the other hand, is considered when the heart rate is between 70% and 80% of the maximum heart rate [15]. The recommendation of the World Health Organization 16] was used to analyze the level of physical activity performed for adults and the elderly, which should be at least 150 to 300 min of moderate intensity throughout the week to have substantial health benefits. Body weight was measured to the nearest 0.1 kg using a digital scale with the subject wearing light clothing and no shoes. Height was measured to the nearest 0.1 cm. Body Mass Index was calculated as follows: body weight divided by the square of the height (kg/m²), providing a measure of body composition. Waist circumference was measured in centimeters using an inextensible millimeter tape [17], was obtained from the midpoint between the iliac crest and the last rib, considering the following cutoff point for increased risk for health complications: men ≥ 94 cm and women ≥ 80 cm [18]. SBP and DBP were measured by a trained health professional, using a mercury sphygmomanometer on the left arm, with the patient sitting and at rest. Biological material (blood) was obtained from the patient’s clinical records. The following laboratory tests were analyzed: fasting blood glucose (mg/dL), HbA1c (%), total cholesterol (mg/dL), HDL-c (mg/dL) and triglycerides (mg/dL). These parameters were measured using an automatic sequential analyzer with a commercial diagnostic kit performed in the same laboratory, whose reference values, in fasting, were: fasting blood glucose: between 70 and 100 mg/dL; HbAa1c < 5.7%; total cholesterol < 190 mg/dL; HDL > 40 mg/dL and triglycerides < 150 mg/dL. The questionnaire, anthropometric, clinical, physical and laboratory measurements were carried out/obtained by the team during the interview with the participants at the T0 (baseline) and T1 (follow-up). Description of the intervention In our study, we refer to the type of intervention aimed at the public that did not receive digital health-based guidance, as proposed in our studies based on NUTELES/UFV, as mentioned previously, as a traditional intervention. The guidance was provided individually during consultations, in accordance with the care routine of primary health care services. The actions carried out in this context were based on care through conventional consultations in basic health units, conducted by primary care professionals, focusing on health education and the clinical management of underlying diseases. The focus was on glycemic control and blood pressure control through positive changes related to behavioral factors, which directly influence the control of AH and diabetes. During contact with patients, they received standardized guidance through a previously prepared script on: (1) healthy eating, with emphasis on reducing consumption of sodium, added sugar and saturated fats, as well as increasing the intake of fruits, vegetables, legumes and fiber, in addition to adequate control of portions of each food category; (2) recommendations on the practice of appropriate and safe physical activity, with light to moderate intensity, according to the individuality of each patient and respecting the recommendations contained in the guides and guidelines cited above; (3) educational guidance on the chronic nature of diseases, their risk factors, possible complications and the importance of adherence to drug and non-drug treatment. Finally, we focus on self-care as a central component of management, including regular monitoring of blood pressure and/or capillary blood glucose when indicated, correct and continuous use of prescribed medications, recognition of signs and symptoms of disease imbalance, maintenance of healthy lifestyle habits and timely seeking of care in case of clinical changes. No serious adverse events related to the intervention were identified during the follow-up period. All occurrences were reported to the research team and, when clinically indicated, participants were referred for appropriate medical care within the primary health care network. Definition of variables The following covariates were considered in this study: (1) sociodemographic: age (continuous); sex (male and female); race (white, black, brown and others); education (no education, elementary to elementary and up to higher education); residence (rural and urban) and marital status (single, married, separated, widowed); (2) adverse events: diagnosis of COVID-19; (3) assessment of risk factors: smoking (yes, no and ex-smoker), alcohol consumption (yes, no and ex-alcoholic); (4) level of physical activity: light and moderate (continuous); (5) clinical evaluation: SBP and DBP (continuous); (6) laboratory tests (continuous). The variables related to health status: presence of Diabetes only (group 1), AH only (group 2) and Diabetes and AH (group 3), are the dependent variables. We emphasize that all patients in our sample had previously been diagnosed with hypertension and/or diabetes based on the following criteria: Hypertension was defined as systolic blood pressure (SBP) ≥ 140 mmHg and/or diastolic blood pressure (DBP) ≥ 90 mmHg and/or a self-reported history of hypertension and current use of antihypertensive medications [19]. Diabetes was also previously diagnosed based on the criteria of fasting blood glucose ≥ 7.0 mmol/L; HbA1c level ≥ 6.5%; prior diagnosis of diabetes; and use of medication for the disease or regular insulin injections [20]. For this reason, all patients in the sample use medications to control the aforementioned conditions. Changes in covariates were calculated as the difference between follow-up and baseline values (T1 − T0), used for between-group comparisons. All covariates and the dependent variable were collected at baseline and at follow-up. Missing data were handled using complete-case analysis, with only participants for whom information was available for the variables of interest at each assessment time point included in the analyses. The number of observations varied across analyses depending on data availability. Statistical analysis Participants were classified according to their comorbidities: diabetes only (Group 1), hypertension only (Group 2), and both diabetes and hypertension (Group 3). Participant characteristics were presented as continuous variables (mean and standard deviation or median with interquartile range) or categorical variables (frequency and proportions). Baseline values (T0) and changes in parameters at three-year period (T1) were compared between groups according to the presence or absence of AH and/or diabetes. All continuous variables were tested for normality using the Kolmogorov–Smirnov or Shapiro–Wilk tests, as appropriate. Variables with a normal distribution were described by mean and standard deviation and analyzed using parametric methods, while non-normally distributed variables were described by median and interquartile range and analyzed using nonparametric methods. Comparisons between groups were performed using one-way analysis of variance (ANOVA) for normally distributed continuous variables, given its robustness and suitability for simultaneous comparison of means across multiple independent groups, and the Kruskal–Wallis H test for non-normally distributed variables. For categorical variables, the chi-square test (χ²) was used. Distributions in the variables were analyzed among the three groups categorized by the presence of comorbidities at the start of the study and by changes observed during follow-up. When statistically significant differences were identified, post hoc analyses were performed for multiple comparisons, using Tukey’s test following ANOVA and Dunn’s test with Bonferroni correction following the Kruskal–Wallis test, in order to identify specific differences between the groups. In addition to statistical significance, the magnitude of the differences was assessed using Cohen’s d for between-group comparisons, with their respective 95% confidence intervals (95% CI). For within-group analyses (comparisons between T0 and T1), the effect size was also estimated using Cohen’s d, interpreted as an approximate measure, since the correlation coefficient between repeated measures was not considered. The magnitude of the effects was classified according to conventional criteria as small (d = 0.2), moderate (d = 0.5), and large (d ≥ 0.8) [21]. A p-value < 0.05 was considered statistically significant. All analyses were performed using the Statistical Package for the Social Sciences (SPSS) version 22.0 for Windows (IBM Corp., Armonk, NY, USA). Results Of the 375 people who met the inclusion criteria, 357 agreed to participate in the study and signed the informed consent form; 24 are in Group 1 (diabetes diagnosis only), 212 are in Group 2 (AH only), and 121 are in Group 3 (diabetes and AH). The baseline anthropometric (BMI and Waist Circumference), behavioral (level of light and moderate physical activity and lifestyle habits) and clinical (blood pressure levels and laboratory tests) parameters of the participants with the respective calculated scores presented in Table 1. In addition, all these baseline variables are tabulated and calculated in all cases by group. Table 1Baseline characteristics of adults and elderly individuals according to comorbidity groupCharacteristicsGroup 1N = 24Group 2N = 212Group 3N = 121p-ValueAge (Years)59,5 ± 12,663,9 ± 12,363,8 ± 12,70,258Sex0,068 Male6 (5,6)74 (68,5)28 (25,9) Female18 (7,2)138 (55,4)9 (37,3)Race0,842 White11 (7,8)79 (56,0)51 (36,2) Black8 (6,7)74 (61,7)38 (31,7) Brown and Others5 (5,2)59 (61,5)32 (33,3)Education0,648 No education5 (8,3)37 (61,7)18 (30,0) Basic to elementary13 (5,6)135 (58,2)84 (36,2) Elementary to higher education6 (9,2)40 (61,5)19 (29,2)Location of the house0,358 Rural Area4 (4,5)58 (65,9)26 (29,5) Urban Area19 (7,1)154 (57,7)94 (35,2)Marital status0,193 Single6 (13,0)29 (63,0)11 (23,9) Married12 (7,0)94 (55,0)65 (38,0) Separated1 (2,4)24 (57,1)17 (40,5) Widowed5 (5,6)59 (65,6)26 (28,9)COVID Diagnosis1 (1,4)41 (55,4)32 (43,2)0,033Smoker0,267 Yes3 (4,3)48 (68,6)19 (27,1) No13 (6,4)113 (55,9)76 (37,6) Ex-smoker8 (9,8)49 (59,8)25 (30,5)Alcohol use0,736 Yes2 (3,6)37 (66,1)17 (30,4) No18 (7,2)144 (57,8)87 (34,9) Former alcoholic4 (8,7)27 (58,7)15 (32,6)Light physical activity (min/week)0,0(0,0-255,0)50,0(0,0-180,0)40,0(0,0-180,0)0,994Moderate physical activity (min/week)0,0(0,0-240,0)0,0(0,0-240,0)0,0(0,0-240,0)0,992SBP (mmHg)127,9 ± 20,7132,6 ± 21,0134,6 ± 22,30,270DBP (mmHg)77,3 ± 9,982,5 ± 12,282,3 ± 12,30,105BMI (kg/m²)27,8 ± 4,528,8 ± 8,130,3 ± 8,80,226Waist circumference (cm)98,1 ± 13,096,5 ± 14,9101,4 ± 14,00,016Fasting Blood Glucose (mg/dL)156,8 ± 69,494,3 ± 18,9141,6 ± 53,1< 0,001HbA1c (%)8,5 ± 1,95,9 ± 1,37,8 ± 2,2 < 0,001 Creatinine (mg/dL)0,9 ± 0,21,0 ± 1,01,1 ± 1,10,781Total Cholesterol (mg/dL)190,7 ± 35,0191,4 ± 45,1196,3 ± 155,60,078Triglycerides (mg/dL)191,0(129,0-280,0)120,0(91,0-176,0)137,0(90,0-193,0)0,084HDL-c (mg/dL)48,0 ± 14,251,6 ± 16,449,1 ± 12,20,472One-way, Kruskal–Wallis H Test for skewed variables and Pearson chi-squared tests for categorical variables; The results are presented as the mean ± standard deviation (SD) for variables with a symmetric distribution; as the median (interquartile range—IQR) for variables with an asymmetric distribution and absolute number and percentage [n (%)] for categorical variablesBMI Body Mass Index, SBP Systolic Blood Pressure, DBP Diastolic Blood Pressure, HbA1c Glycated Hemoglobin, HDL High Density Lipoproteinp-values shown in bold indicate a statistically significant difference (p < 0.05) Baseline characteristics of adults and elderly individuals according to comorbidity group One-way, Kruskal–Wallis H Test for skewed variables and Pearson chi-squared tests for categorical variables; The results are presented as the mean ± standard deviation (SD) for variables with a symmetric distribution; as the median (interquartile range—IQR) for variables with an asymmetric distribution and absolute number and percentage [n (%)] for categorical variables BMI Body Mass Index, SBP Systolic Blood Pressure, DBP Diastolic Blood Pressure, HbA1c Glycated Hemoglobin, HDL High Density Lipoprotein p-values shown in bold indicate a statistically significant difference (p < 0.05) With regard to sociodemographic characteristics, there were no significant differences between the groups in terms of age (mean 63 years), sex, race, educational level, residential location, and marital status. The majority of participants were female in all groups. There was a significant difference in the diagnosis of COVID-19 among the groups (p = 0.033), which may reflect greater vulnerability of certain profiles of chronic patients to infection. Regarding lifestyle habits, the parameters remained unchanged among the groups. Regarding clinical and metabolic parameters, Group 3 presented the data with the greatest variability, which is expected in patients with multiple chronic diseases, such as fasting blood glucose, HbA1c and waist circumference levels, all of which showed statistically significant differences, as demonstrated in the Table 1. Changes in the values ​​of each variable within groups and between groups over the study period are shown in Table 2; Fig. 2. From T0 to T1, within-group comparisons indicated a significant decline in light and moderate physical activity levels in Group 2 (p < 0.001). In Group 3, a significant reduction in light physical activity was observed (p = 0.003), along with an improvement in HbA1c levels (d = − 0.40; p = 0.034), SBP and DBP levels (p = 0.025 and p = 0.003, respectively) and BMI levels (p = 0.003). In Group 1, no significant changes were observed over time. Between-group comparisons at T1 revealed a significant difference in triglycerides, with a moderate effect size (d = 0.53; 95% CI: 0.30–0.76; p = 0.009). For HbA1c, a small to moderate effect was identified (d = − 0.39; 95% CI:−0.78 to − 0.01; p = 0.052), which should be interpreted cautiously as the confidence interval includes values close to zero and a threshold p-value. Table 2Anthropometric, clinical and physical activity parameters at the beginning and end of the three-year periodVariablesGroup 1(n = 24)Group 2(n = 212)Group 3(n = 121)p-ValuebPost-hoc*0 year3 yearsp-Valuea0 year3 yearsp-Valuea0 year3 yearsp-ValueaLight physical activity(min/week)0,0(0,0-255,0)0,0(0,0–0,0)0,19650,0(0,0-180,0)0,0(0,0–99,0)< 0,00140,0(0,0-180,0)0,0(0,0–99,0)0,0030,043Group 3Moderate physical activity0,0(0,0-240,0)0,0(0,0–0,0)0,1090,0(0,0-240,0)0,0(0,0–99,0)< 0,0010,0(0,0-240,0)0,0(0,0-120,0)0,1260,970SBP (mmHg)131,4 ± 27,7130,4 ± 18,00,929132,1 ± 18,6129,0 ± 21,20,068136,4 ± 22,0129,7 ± 20,40,0250,634DBP (mmHg)79,5 ± 11,281,7 ± 12,30,39881,2 ± 11,480,9 ± 16,90,13182,7 ± 12,878,2 ± 11,5 0,003 0,226BMI (kg/m²)27,0 ± 4,526,3 ± 4,00,08629,3 ± 8,428,3 ± 7,00,06130,1 ± 10,028,1 ± 5,2 0,003 0,269Waist circumference (cm)98,0 ± 12,198,0 ± 12,50,87896,4 ± 16,396,3 ± 17,30,99699,3 ± 13,598,5 ± 12,9 0,405 0,614Fasting Blood Glucose (mg/dL)174,0 ± 43,8155,0 ± 21,20,18092,0 ± 20,293,4 ± 15,60,561136,0 ± 52,0129,7 ± 20,40,7800,071Group 2HbA1c (%)8,7 ± 0,28,7 ± 0,71,0005,5 ± 1,714,4 ± 32,70,4328,0 ± 2,07,2 ± 1,40,0340,052Group 3Creatinine (mg/dL)0,7 ± 0,00,8 ± 0,00,3170,9 ± 0,41,2 ± 1,00,2230,9 ± 0,31,0 ± 0,2 0,586 0,618Total Cholesterol (mg/dL)151,0 ± 0,0155,5 ± 6,40,317196,0 ± 65,9184,2 ± 45,40,538167,8 ± 70,0171,9 ± 43,10,5300,073Group 3Triglycerides (mg/dL)57,0 ± 0,057,0 ± 0,01,000125,0 ± 60,4114,0 ± 39,80,264126,5 ± 61,4150,0 ± 87,20,8260,009Group 3HDL-c (mg/dL)63,0 ± 14,257,0 ± 22,60,31753,8 ± 18,052,4 ± 14,50,74550,4 ± 15,150,5 ± 13,10,9090,114Results are presented as mean ± SD for the normally distributed variables or as median and interquartile range (25th–75th percentile) for the skewed variablesBMI Body Mass Index, SBP Systolic Blood Pressure, DBP Diastolic Blood Pressure, HbA1c Glycated Hemoglobin, HDL High Density Lipoproteinap-values derived through paired-samples Student t-test or related-samples Wilcoxon signed-rank test (within-group comparisons)bp-values derived through one-way ANOVA or Kruskal–Wallis H-test (between-group comparisons)*post-hoc Tukey or Dunnett test: Group with greatest differencep-values shown in bold indicate a statistically significant difference (p < 0.05) Anthropometric, clinical and physical activity parameters at the beginning and end of the three-year period Results are presented as mean ± SD for the normally distributed variables or as median and interquartile range (25th–75th percentile) for the skewed variables BMI Body Mass Index, SBP Systolic Blood Pressure, DBP Diastolic Blood Pressure, HbA1c Glycated Hemoglobin, HDL High Density Lipoprotein ap-values derived through paired-samples Student t-test or related-samples Wilcoxon signed-rank test (within-group comparisons) bp-values derived through one-way ANOVA or Kruskal–Wallis H-test (between-group comparisons) *post-hoc Tukey or Dunnett test: Group with greatest difference p-values shown in bold indicate a statistically significant difference (p < 0.05) Changes in light physical activity, fasting blood glucose, HbA1c, total cholesterol, and triglycerides, and between-group differences at T1 Results are presented as mean and standard deviation. p-values derived through one-way, Kruskal–Wallis H Test for skewed variables and Pearson chi-squared tests for categorical variables. HbA1c: Glycated Hemoglobin Discussion This study analyzed data from a three-year prospective community-based follow-up cohort study conducted among adults and elderly individuals diagnosed with AH and/or Diabetes at baseline. Within-group comparisons revealed significant changes in light and moderate physical activity (Group 2) and in light physical activity, SBP, DBP, BMI and HbA1c levels (Group 3). Between-group comparisons at T1 showed significant differences in light physical activity (p = 0.043) and triglycerides (p = 0.009). It is known that both AH and Diabetes can be caused by a complex combination of risk factors, many of which are modifiable, such as diet quality, physical inactivity, smoking and alcoholism [22–24]. As both diseases are progressive, some of these risk factors can be more easily controlled over time. Some studies have reported a strong association between diet quality and the level of physical activity [25–27]. Our specific study didn’t assess diet quality; however, the triglycerides worsened significantly over time, which may help us to draw up a profile of this population. The study by Diaz KM and Shimbo [28] highlights that chronic lack of physical activity, i.e., a sedentary lifestyle, is one of the main risk factors for AH and Diabetes. These results corroborate other studies which show that the higher the level of physical activity, the better the control of blood pressure, cardiovascular health as a whole, the inhibition of insulin resistance and body inflammation [29, 30]. However, the study by Yih-Jian Tsai [31] addresses a different aspect within this context, pointing out that older individuals often do not take part in physical activity for fear of the risk of falling. In our study, the majority of the population is older. The fact that there is no targeted and regular intervention can further increase this fear and, consequently, the practice of physical activity. In the context of multimorbidity, a central characteristic of Group 3 in this study, composed of individuals with a simultaneous diagnosis of AH and diabetes, improved glycemic control becomes even more relevant. Lifestyle interventions aimed at managing cardiometabolic multimorbidity, combining physical activity, nutritional guidance, and support in primary care, represent promising strategies for reducing cardiovascular risk and improving clinical outcomes in this population [32]. Furthermore, the coexistence of these two underlying chronic diseases amplifies the difficulties in adhering to self-care and increases the risk of complications, making integrated and patient-centered approaches a priority in the management of these conditions at the primary care level. The reduction in light physical activity, HbA1c, SBP, DBP and BMI levels observed in Group 3 over the three-year follow-up period is consistent with the literature, which demonstrates the effectiveness of multifactorial behavioral interventions in controlling blood glucose and blood pressure. A systematic review conducted in 2025, which aimed to evaluate the effectiveness of behavioral intervention programs in diabetes control in adults, identified that these programs (encompassing diet, physical activity, and treatment adherence) promoted average reductions in HbA1c between − 0.3% and − 0.7% (Cohen’s d ≈ 0.28) in adults with diabetes or at risk for the disease [33]. The magnitude of the effect found in the present study (d = -0.40) falls within this range, reinforcing the clinical coherence of the results obtained. We would also like to highlight the study by Regina de Sá et al. [34] which investigated the association between area-level walkability and individual HbA1c levels in an adult population with Diabetes. The findings indicated that residing in moderately walkable areas significantly reduced average HbA1c levels, emphasizing the potential policy implications for Diabetes prevention and health promotion. This issue raised is one of the barriers that individuals find to practicing physical activity outdoors, which can be a limiting factor for this practice. For this reason, knowing the population, the environment in which they live and the social determinants of health that surround them is of the utmost importance for applying more assertive and effective interventions [35]. On the other hand, although physical activity is considered to be one of the main determinants of chronic diseases when it comes to risk factors, especially for AH and Diabetes, the World Health Organization [16] points out that globally, a quarter of adults don’t reach the minimum recommended levels of physical activity. Once again, physical activity combined with other behavioral factors and lifestyle habits are considered important protective factors for non-communicable diseases [9, 36]. In relation to the lipid profile, specifically triglycerides which increased over time in the cohort, we highlight that they are important predictors of both Diabetes and AH. Xuyang Meng et al. [37] identified in a large cohort that the triglyceride-glucose index was independently associated with hospital death and was an independent risk predictor for all-cause mortality. Although we are talking about a tertiary care setting, it is important to point out that these high predictors, when not adequately treated through appropriate interventions, can lead to extremely serious consequences for patients, especially those who have two or more comorbidities, as is the case with our study population. In context of the type of intervention, we highlight a systematic review with meta-analysis carried out in 2023 [38] which confirms the author’s hypothesis that the type of intervention used influences the final result of behavioral changes. In this study, it was proven that the use of mobile health apps as a digital intervention improves the management, self-monitoring and monitoring of AH and Diabetes in adults and the elderly when compared to traditionally employed strategies, which is the case of our study in question, which didn’t use any innovative and continuous intervention. Nevertheless, the use of technology in the health area and the current technological advances focused on the management of health services and care, have received great encouragement and support from the World Health Organization and have become a key element in the 21st century [39, 40]. It is concluded that Brazil is on the right track for the management of chronic diseases, however, in order to achieve greater harmony with the proposals of the World Health Organization, it is necessary to innovate the interventions currently used to improve the health and well-being of the population [12]. Limitations and strength This study had some limitations that should be acknowledged. First, laboratory tests were performed only twice: at the start of the study and after the three-year period; therefore, changes more significant than those found were not detected. Second, physical activity was assessed through self-report using the IPAQ, which is subject to memory bias and overestimation of the level and duration of physical activity, potentially resulting in inaccurate classification. Although the instrument is widely validated and used in epidemiological studies, especially in primary care settings due to its feasibility and low cost, self-reported measures may not accurately reflect actual levels of physical activity when compared to more objective methods. Thus, results related to physical activity should be interpreted with caution. Third, potential confounding factors and analyses adjusted for comorbidities related to AH and/or diabetes, such as chronic kidney disease, could not be performed due to the lack of complete data; however, these comorbidities may have a greater influence on the responses of the variables studied. Finally, we acknowledge that the accuracy of the results may be compromised by unobserved factors, such as the use of pharmacological regimens. However, it is worth noting that this is a 3-year cohort of patients previously diagnosed with AH and/or diabetes who were receiving ongoing treatment for these conditions—situations in which medication use is an integral part of clinical management. We interpret the results within the context of standard care for this population, which also lends greater external validity to the findings. We acknowledge that future studies should consider the analytical monitoring of medications in use. Future research, as well as studies by the NUTELES-UFV team itself, should aim to incorporate variables not yet studied to increase the robustness of the analyses and research. Despite its limitations, this study also makes important contributions to research in this field. First, we highlight the comparative analysis of three different groups that received the same intervention (traditional monitoring by health clinics) for two major underlying conditions: diabetes and hypertension. Second, we emphasize that the study is part of a larger ongoing cohort, the NUTELES-UFV project, which integrates different aspects of telehealth in our region’s health micro-region. Subsequently, this project will be expanded to other regions of our country, becoming a benchmark for telehealth centers in primary care for individuals with risk factors and a diagnosis of diabetes and/or AH. This will support future long-term follow-up studies that will certainly contribute to findings relevant to public health. Third, there is the nature of the study design: a cohort, which is a standardized methodology used across all study groups. Implications for policy and practice We emphasize that our study provides important insights for future research. Our findings suggest the need to research populations that present more than one comorbidity, especially when considering diseases that are so prevalent and proven to be a serious public health problem worldwide, such as AH and diabetes. Dynamic cohorts in different regions of the world, with different populations and with diseases of high prevalence and mortality rates, can be generalized and provide results of great impact for reducing the medium and long-term consequences of these diseases at the community level. Specifically, our study highlights the importance of considering modifiable and dynamic risk factors in the treatment of the diseases studied, which may have significant implications for clinical practice and, especially, for public health at the primary care level. Finally, we emphasize the importance of more innovative, assertive interventions focused on multimorbidity and multicausality. Conclusions This study demonstrates that there are effective strategies that can reduce the burden on health services through proper management of multimorbidity, particularly at the primary care level, which serves as the gateway to a universal public health system, as is the case of the Brazilian Unified Health System. Our cohort study prospective assessed of baseline levels of clinical, physical, and behavioral parameters in adults and older adults with two major chronic conditions, can serve as a useful resource for improving integrated intervention strategies and for identifying behavioral barriers that hinder adequate control of AH and diabetes. Although improvements in the parameters analyzed did not occur in all analysis groups, our results suggest that lifestyle improvements are positively associated with changes in cardiometabolic indicators; Nevertheless, although group interventions are important and encouraging, an individualized approach may increase patient engagement and promote supported self-care. Combining these two approaches can be very beneficial for patients. Limitations must be acknowledged, such as the absence of an assessment of dietary intake, which limits our ability to link nutritional factors to the observed outcomes. Despite this limitation, our study design, combined with a longitudinal assessment of the parameters analyzed in the primary care setting, provides important insights into the potential role of lifestyle factors on cardiometabolic outcomes. Finally, this study supports the development of more effective strategies for long-term management in a setting of multimorbidity. We invite future researchers and clinicians to build upon these findings and share their experiences in this same settings, but with different approaches and diverse sociocultural conditions. Supplementary Information Supplementary Material 1. Supplementary Material 2. Acknowledgements We would like to thank the project team, which is part of the Innovation Program in University Teaching (PRODUS) and the Health Planning and Management Studies Laboratory (LabPlanGest) at the Federal University of Viçosa (UFV), the Telehealth Center at UFV (NUTELES-UFV) and the Database and Software Engineering Laboratory at the Federal University of Tocantins. The study was made possible by partnerships between the Federal University of Viçosa (UFV), the Municipal Health Department of Viçosa, Minas Gerais, the Minas Gerais State Health Department (SES-MG) and the Federal University of Tocantins (UFT). We would also like to thank all the funding agencies that supported this research and its researchers. Abbreviations Arterial Hypertension Telehealth Center of the Federal University of Viçosa Statistical Package for Social Science Brazilian Registry of Clinical Trials Systolic Blood Pressure Diastolic Blood Pressure Glycated Hemoglobin High Density Lipoprotein Authors' contributions E.S.F. contributed to the literature, designed the study, collected, analyzed the dada and drafted the manuscript. V.S.A, L.C.O., M.D.P. and T.I.S.N. collected the data. T.R.M. and G.D.C. contributed to the supervised the data analysis and revision of the manuscript; R.M.M.C. contributed to the designed the study, supervised the data analysis and contributed to the drafted and revision of the manuscript for final approval. Funding This study was funded by the Research Support Foundation of the State of Minas Gerais (FAPEMIG), process nº APQ-02708-21. ESF is funded by a scholarship from the National Council for Scientific and Technological Development (CNPq). Data availability Data is provided within the manuscript. Declarations Ethics approval and consent to participate The research project was approved by the Human Research Ethics Committee of UFV, under opinion no. 4.475.901 and registered, prior to recruitment, by the Brazilian Registry of Clinical Trials (ReBEC), ID: RBR-45hqzmf (Last approval date: 11/30/2022). All methods were carried out in accordance with relevant guidelines and regulations (Declaration of Helsinki). All individuals provided written informed consent before participating in the study. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Supplementary Material 1. Supplementary Material 2. Data Availability Statement Data is provided within the manuscript.